Report cover image

Medical Device CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Target Therapeutic Area, Scale of Operation, Device Class, Type of Clinical Service Offered, Type of Preclinical Service Offered and Key Geographies:

Publisher Roots Analysis
Published Dec 04, 2025
Length 560 Pages
SKU # ROAL20636302

Description

Medical Device CRO Market: Overview

As per Roots Analysis, the global medical device CRO market is estimated to grow from USD 13.3 billion in the current year to USD 19.3 billion by 2035, at a notable CAGR during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Scale of Operation 
  • Clinical
  • Preclinical 
Device Class 
  • Class 1 
  • Class 2 
  • Class 3
Type of Clinical Services Offered
  • Clinical Trial Management 
  • Data Management 
  • Regulatory Affair Management
  • Consulting
Type of Preclinical Services Offered 
  • Biocompatibility Testing
  • Sterility
  • Microbiology Testing
  • Material Characterization
  • Analytical Services 
Target Therapeutic Area 
  • Cardiovascular Disorders
  • CNS Disorders
  • Metabolic Disorders
  • Oncological Disorders
  • Ophthalmological Disorders
  • Orthopedic Disorders
  • Pain Disorders
  • Psychological Disorders
  • Respiratory Disorders
  • Others
Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Medical Device CRO Market: Growth and Trends

The rise in the elderly population and the prevalence of illnesses, especially chronic conditions, has resulted in a growing need for innovative medical devices in various therapeutic fields. Since 2020, approximately 105 medical devices have been approved by the USFDA. Additionally, it is interesting to highlight that more than 35 medical devices obtain FDA approval every year. Nonetheless, a key challenge encountered by this sector is the lengthy and complicated product development process of a new medical device. The clinical phase is highly resource-demanding, involving increased expenses and elevated risks. Further, the strict regulatory standards to guarantee the security of medical devices complicate the operations for industry leaders.

To circumvent the aforementioned bottleneck, developers of medical devices are increasingly outsourcing their research activities to specialized medical device CROs. These entities provide knowledge in executing clinical studies, managing regulatory demands, and maintaining adherence to safety regulations. By closely collaborating with manufacturers, CROs facilitate the transformation of innovative concepts into market-ready products, while diligently overseeing the entire product development lifecycle. Moreover, the landscape of medical devices is swiftly evolving, propelled by the incorporation of innovative technologies and tools, such as risk monitoring systems, sophisticated data analytics, real-world evidence solutions, and cloud computing. Due to continuous research and development, along with the growing opportunities related to the medical devices market, it is expected that the medical devices CRO market will experience significant growth in the next ten years.

Medical Device CRO Market: Key Insights

The report delves into the current state of the medical device CRO market and identifies potential growth opportunities within the industry. Some key findings from the report include:
  • More than 590 CROs currently claim to have the required capabilities to offer a wide range of research and analytical services for medical devices, across different scale of operation.
  • The market is well fragmented, featuring a mix of players based across different geographical regions that provide services for a range of medical device classes.
  • In pursuit of building a competitive edge, medical devices CROs are actively upgrading / expanding their capabilities to enhance their respective portfolios of offerings.
  • Over the years, industry players have undertaken a variety of initiatives to further advance the development / enable the improvement of their proprietary services for medical devices.
  • The rising interest in this domain is reflected in the number of mergers and acquisitions that have been reported in the last few years; 53% of such initiatives were focused on geographical consolidation.
  • Over 14,000 trials, enrolling close to 4.6 million patients suffering from a myriad of disease indications, have been registered across the globe to evaluate the efficacy and accuracy of medical devices.
  • Our proprietary total cost of ownership model suggests an informed estimate of direct and indirect expenses while setting up a contract research facility in different regions over a span of 20 years.
  • Driven by the ongoing efforts of industry stakeholders, the medical devices contract research service providers the market is expected to witness steady growth in the coming decade.
Medical Device CRO Market: Key Segments

Currently, Clinical Operations Segment Occupies the Largest Share of the Medical Device CRO Market

In terms of the scale of operation, the market is segmented into clinical and preclinical services. At present, the clinical services sector captures the largest share of the medical device CRO market. Notably, the rising number of clinical trials focused on medical devices is expected to propel the market in the short-term.

Class II Devices Segment is the Fastest Growing Segment of the Medical Device CRO Market During the Forecast Period

In terms of the device class, the market is segmented into Class I, Class II, Class III. Currently, class II devices hold maximum share within the medical devices CRO market. This trend is unlikely to change in the short-mid-term.

Currently, Clinical Trial Management Segment Occupies the Largest Share of the Medical Device CRO Market

In terms of the type of clinical services, the market is segmented into clinical trial management, data management, regulatory affairs management, and consulting. Currently, clinical trial management dominates the medical devices CRO market. This pattern is expected to persist in the coming years.

Biocompatibility Testing Services Segment is the Fastest Growing Segment of the Medical Device CRO Market During the Forecast Period

In terms of the type of preclinical services, the market is segmented into biocompatibility testing, sterility, microbiology testing, material characterization, and analytical services. It is worth highlighting that, at present, sterility and microbial testing holds a larger share of the medical device CRO market. This trend is likely to remain the same in the coming decade.

Currently, CNS Disorders Segment Occupies the Largest Share of the Medical Device CRO Market

In terms of therapeutic area, the market is segmented into cardiovascular disorders, CNS disorders, metabolic disorders, oncological disorders, ophthalmological disorders, orthopedic disorders, pain disorders, psychological disorders, respiratory disorders and other disorders. It is worth highlighting that majority of the current medical device CRO market is captured by CNS disorders.

North America Accounts for the Largest Share of the Medical Device CRO Market

In terms of key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the world. Majority share is expected to be captured by CROs based in North America. It is worth highlighting that, over the years, the market of the rest of the world is expected to grow at a higher CAGR.

Example Players in the Medical Device CRO Market
  • Avania
  • Charles River Laboratories
  • CROMSOURCE
  • CSSi LifeSciences
  • Eurofins Medical Testing
  • IQVIA
  • Medpace
  • NAMSA
  • Qserve Group
  • WuXi AppTec
Primary Research Overview

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:
  • Chief Executive Officer and Co-founder, Company A
  • Senior Vice President of Business Development and Marketing, Company B
  • Vice President of Global Marketing and Commercial Operations, Company C
  • Head of Business Development, Company D
  • General Manager, Company E
  • Chief Operating Officer, Company F
  • Senior manager, Medical & Clinical Operations, Company G
  • Technical Director and Partner, Company H
  • Director of Business Development, Company I
  • Business Development Manager, Company J
Medical Device CRO Market: Research Coverage
  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the medical device CRO market, focusing on key market segments, including [A] scale of operation, [B] device class, [C] type of clinical services offered, [D] type of preclinical services offered, [E] therapeutic area and [F] geographical regions.
  • Market Landscape: A comprehensive evaluation of contract research organizations involved in the medical device CRO market, considering various parameters, such as [A] year of establishment, [B] company size (in terms of the number of employees), [C] location of headquarters, [D] area of specialization, [E] device class, [F] types of CRO services offered by [F1] clinical service providers, [F2] preclinical service providers and [F3] stand-alone service providers.
  • Regulatory and Reimbursement Landscape Analysis: A discussion on general regulatory guidelines established and issued by major regulatory bodies for medical device approval. In addition, it includes an insightful multi-dimensional heat map analysis, featuring a comparison of the contemporary regulatory and reimbursement scenarios in key geographies across the globe.
  • Company Profiles: In-depth profiles of key industry players offering CRO services for both clinical and preclinical stage development of medical devices, focusing on [A] company overviews, [B] medical device-focused service portfolio, [C] recent developments and [D] an informed future outlook.
  • Competitive Benchmarking Analysis: A competitive benchmarking analysis that emphasizes the primary focus areas of small, mid-sized, and large companies. This analysis compares their existing capabilities within and beyond their respective peer groups based in North America, Europe, Asia-Pacific, and other regions. It offers stakeholders insights into potential strategies for achieving a competitive edge in the industry.
  • Key Performance Indicators: An analysis highlighting the key performance indicators used by sponsor companies to evaluate service providers engaged in the medical device CRO market, based on information gathered via secondary research (for top-ten medical device players) and primary research.
  • Brand Positioning Analysis: A comprehensive analysis of brand positioning for top industry players, highlighting the prevailing perceptions of their proprietary brands.
  • Clinical Trials Analysis: Examination of completed, ongoing, and planned clinical studies of various medical devices, based on parameters like [A] trial registration year, [B] trial phase, [C] current trial status, [D] enrolled patient population, [E] study design, [F] leading industry players (in terms of number of trials conducted), [G] target therapeutic area(s) and [H] key geographical regions.
  • Merger and Acquisitions: A comprehensive examination of the various mergers and acquisitions, focusing on multiple relevant parameters, including [A] year of agreement, [B] type of agreement and [C] geographical location of the companies.
  • Total Cost of Ownership: An in-depth analysis of the total cost of ownership for a medical device contract research service provider, which includes a well-informed estimate of both direct and indirect costs.
  • Survey Analysis: A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing CRO services to medical device developers.
  • SWOT Analysis: A SWOT analysis, focusing on key drivers and challenges that are likely to impact the industry’s evolution. Further, it includes a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall industry.
Key Questions Answered in this Report
  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?
Reasons to Buy this Report
  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

Table of Contents

560 Pages
1. Preface
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. Research Methodology
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape And Market Trends
2.2.2. Market Forecast And Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences And Seminars
2.4.1.9. Government Portals
2.4.1.10. Media And Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases And Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types Of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages Of Primary Research
2.4.2.3. Techniques For Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered In Primary Research
2.4.2.4.1. Company Executives (Cxos)
2.4.2.4.2. Board Of Directors
2.4.2.4.3. Company Presidents And Vice Presidents
2.4.2.4.4. Research And Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors And Other Healthcare Providers
2.4.2.5. Ethics And Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools And Databases
2.5. Robust Quality Control
3. Market Dynamics
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (Tam)
3.3.2. Serviceable Addressable Market (Sam)
3.3.3. Serviceable Obtainable Market (Som)
3.3.4. Currently Acquired Market (Cam)
3.4. Forecasting Tools And Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4. Macro-economic Indicators
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current And Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting The Market
4.2.2.2. Factors Affecting Currency Fluctuations
4.2.2.3. Impact Of Currency Fluctuations On The Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact Of Foreign Exchange Rate Volatility On The Market
4.2.3.2. Strategies For Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment Of Current Economic Conditions And Potential Impact On The Market
4.2.5. Inflation
4.2.5.1. Measurement And Analysis Of Inflationary Pressures In The Economy
4.2.5.2. Potential Impact Of Inflation On The Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates And Their Impact On The Market
4.2.6.2. Strategies For Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type Of Commodity
4.2.7.2. Origins And Destinations
4.2.7.3. Value And Weights
4.2.7.4. Modes Of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies For Mitigating The Risks Associated With Trade Barriers
4.2.8.5. Impact Of Trade Barriers On The Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-ukraine War
4.2.9.2. Israel-hamas War
4.2.10. Covid Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response And Stimulus Measures
4.2.10.4. Future Outlook And Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (Gdp)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross-border Dynamics
4.3. Conclusion
Section Ii: Qualitative Insights
5. Executive Summary
6. Introduction
6.1. Chapter Overview
6.2. Overview Of Medical Devices
6.2.1. Historical Evolution Of Medical Devices
6.2.2. Classification Of Medical Devices
6.3. Overview Of Contract Research Organizations
6.3.1. Evolution Of Cros
6.4. Role Of Cros In The Medical Device Industry
6.5. Type Of Medical Device Cros
6.6. Type Of Services Offered By Cros
6.7. Advantages Of Outsourcing Operations To Cros
6.8. Risks And Challenges Associated With Outsourcing
6.9. Key Considerations For Selecting A Suitable Cro Partner
6.10. Concluding Remarks
7. Regulatory And Reimbursement Landscape For Medical Devices
7.1. Chapter Overview
7.2. Regulatory And Reimbursement Guidelines For Medical Devices
7.3. Regulatory And Reimbursement Landscape In North America
7.3.1. The Us Scenario
7.3.1.1. Regulatory Authority
7.3.1.2. Review / Approval Process
7.3.1.3. Reimbursement Landscape
7.3.1.3.1. Payer Mix
7.3.1.3.2. Reimbursement Process
7.3.2. The Canadian Scenario
7.3.2.1. Regulatory Authority
7.3.2.2. Review / Approval Process
7.3.2.3. Reimbursement Landscape
7.3.2.3.1. Payer Mix
7.3.2.3.2. Reimbursement Process
7.3.3. The Mexican Scenario
7.3.3.1. Regulatory Authority
7.3.3.2. Review / Approval Process
7.3.3.3. Reimbursement Landscape
7.3.3.3.1. Payer Mix
7.4. Regulatory And Reimbursement Landscape In Europe
7.4.1. Overall Scenario
7.4.1.1. Overall Regulatory Authorities
7.4.1.2. Review / Approval Process
7.4.2. The Uk Scenario
7.4.2.1. Regulatory Authority
7.4.2.2. Review / Approval Process
7.4.2.3. Reimbursement Landscape
7.4.2.3.1. Payer Mix
7.4.2.3.2. Reimbursement Process
7.4.3. The French Scenario
7.4.3.1. Regulatory Authority
7.4.3.2. Review / Approval Process
7.4.3.3. Reimbursement Landscape
7.4.3.3.1. Payer Mix
7.4.3.3.2. Reimbursement Process
 
7.4.4. The German Scenario
7.4.4.1. Regulatory Authority
7.4.4.2. Review / Approval Process
7.4.4.3. Reimbursement Landscape
7.4.4.3.1. Payer Mix
7.4.4.3.2. Reimbursement Process
7.4.5. The Italian Scenario
7.4.5.1. Regulatory Authority
7.4.5.2. Review / Approval Process
7.4.5.3. Reimbursement Landscape
7.4.5.3.1. Payer Mix
7.4.5.3.2. Reimbursement Process
7.4.6. The Spanish Scenario
7.4.6.1. Regulatory Authority
7.4.6.2. Review / Approval Process
7.4.6.3. Reimbursement Landscape
7.4.6.3.1. Payer Mix
7.4.6.3.2. Reimbursement Process
7.5. Regulatory And Reimbursement Landscape In Asia-pacific And Rest Of The World
7.5.1. The Australian Scenario
7.5.1.1. Regulatory Authority
7.5.1.2. Review / Approval Process
7.5.1.3. Reimbursement Landscape
7.5.1.3.1. Payer Mix
7.5.1.3.2. Reimbursement Process
7.5.2. The Brazilian Scenario
7.5.2.1. Regulatory Authority
7.5.2.2. Review / Approval Process
7.5.2.3. Reimbursement Landscape
7.5.2.3.1. Payer Mix
7.5.2.3.2. Reimbursement Process
7.5.3. The Chinese Scenario
7.5.3.1. Regulatory Authority
7.5.3.2. Review / Approval Process
7.5.3.3. Reimbursement Landscape
7.5.3.3.1. Payer Mix
7.5.3.3.2. Reimbursement Process
7.5.4. The Indian Scenario
7.5.4.1. Regulatory Authority
7.5.4.2. Review / Approval Process
7.5.4.3. Reimbursement Landscape
7.5.4.3.1. Payer Mix
7.5.5. The Israeli Scenario
7.5.5.1. Regulatory Authority
7.5.5.2. Review / Approval Process
7.5.5.3. Reimbursement Landscape
7.5.5.3.1. Payer Mix
7.5.6. The Japanese Scenario
7.5.6.1. Regulatory Authority
7.5.6.2. Review / Approval Process
7.5.6.3. Reimbursement Landscape
7.5.6.3.1. Payer Mix
7.5.6.3.2. Reimbursement Process
7.5.7. The New Zealand Scenario
7.5.7.1. Regulatory Authority
7.5.7.2. Review / Approval Process
7.5.7.3. Reimbursement Landscape
7.5.7.3.1. Payer Mix
7.5.7.3.2. Reimbursement Process
7.5.8. The Singapore Scenario
7.5.8.1. Regulatory Authority
7.5.8.2. Review / Approval Process
7.5.8.3. Reimbursement Landscape
7.5.8.3.1. Payer Mix
7.5.8.3.2. Reimbursement Process
7.5.9. The South African Scenario
7.5.9.1. Regulatory Authority
7.5.9.2. Review / Approval Process
7.5.9.3. Reimbursement Landscape
7.5.9.3.1. Payer Mix
7.5.9.3.2. Reimbursement Process
7.5.10. The South Korean Scenario
7.5.10.1. Regulatory Authority
7.5.10.2. Review / Approval Process
7.5.10.3. Reimbursement Landscape
7.5.11. The Taiwan Scenario
7.5.11.1. Regulatory Authority
7.5.11.2. Review / Approval Process
7.5.11.3. Reimbursement Landscape
7.5.11.3.1. Payer Mix
7.5.11.3.2. Reimbursement Process
7.5.12. The Thailand Scenario
7.5.12.1. Regulatory Authority
7.5.12.2. Review / Approval Process
7.5.12.3. Reimbursement Landscape
7.6. Comparison Of Regional Regulatory Control
7.7. Concluding Remarks
Section Iii: Competitive Landscape 
8. Medical Device Preclinical Cros: Market Landscape
8.1. Chapter Overview
8.2. Medical Device Preclinical Cros: Overall Market Landscape
8.2.1. Analysis By Year Of Establishment
8.2.2. Analysis By Company Size
8.2.3. Analysis By Location Of Headquarters
8.2.4. Analysis By Company Size And Location Of Headquarters
8.2.5. Analysis By Type Of Company
8.2.6. Analysis By Type Of Preclinical Service Offered
9. Medical Device Clinical Cros: Market Landscape
9.1. Chapter Overview
9.2. Medical Device Clinical Cros: Overall Market Landscape
9.2.1. Analysis By Year Of Establishment
9.2.2. Analysis By Company Size
9.2.3. Analysis By Location Of Headquarters
9.2.4. Analysis By Type Of Company
9.2.5. Analysis By Class Of Medical Device
9.2.6. Analysis By Type Of Clinical Trial Service Offered
9.2.7. Analysis By Type Of Regulatory Service Offered
9.2.8. Analysis By Type Of Medical Device Regulatory Compliance Authority
9.2.9. Analysis By Type Of Additional Service Offered
10. Brand Positioning Analysis: Preclinical Medical Device Cros
10.1. Chapter Overview
10.2. Assumptions And Key Parameters
10.3. Methodology
10.4. Brand Positioning Analysis : Preclinical Cros
10.4.1. Brand Positioning Analysis: Accuprec Research Labs
10.4.2. Brand Positioning Analysis: Alera Labs
10.4.3. Brand Positioning Analysis: Eurofins Medical Device Testing
10.4.4. Brand Positioning Analysis: Fortrea
10.4.5. Brand Positioning Analysis: Iuvo Bioscience
10.4.6. Brand Positioning Analysis: Namsa
10.4.7. Brand Positioning Analysis: Sipra Labs
10.4.8. Brand Positioning Analysis: Tentamus
10.4.9. Brand Positioning Analysis: Veranex
10.4.10. Brand Positioning Analysis: Wuxi Apptec
11. Competitive Benchmarking: Clinical Cros
11.1. Chapter Overview
11.2. Assumptions And Methodology
11.3. Competitive Benchmarking By Location Of Headquarters And Company Size
11.3.1. Competitive Benchmarking: Small Players Based In North America (Peer Group I)
11.3.2. Competitive Benchmarking: Mid-sized Players Based In North America (Peer Group Ii)
11.3.3. Competitive Benchmarking: Large And Very Large Players Based In North America (Peer Group Iii)
11.3.4. Competitive Benchmarking: Small Players Based In Europe (Peer Group Iv)
11.3.5. Competitive Benchmarking: Mid-sized Players Based In Europe (Peer Group V)
11.3.6. Competitive Benchmarking: Large And Very Large Players Based In Europe (Peer Group Vi)
11.3.7. Competitive Benchmarking: Small Players Based In Asia-pacific (Peer Group Vii)
11.3.8. Competitive Benchmarking: Mid-sized Players Based In Asia-pacific (Peer Group Viii)
11.3.9. Competitive Benchmarking: Large And Very Large Players Based In Asia-pacific (Peer Group Ix)
11.3.10. Competitive Benchmarking: Small Players Based In Middle East And North Africa, And Latin America (Peer Group X)
11.3.11. Competitive Benchmarking: Mid-sized Players Based In Middle East And North Africa, And Latin America (Peer Group Xi)
11.3.12. Competitive Benchmarking: Large And Very Large Players Based In Middle East And North Africa, And Latin America (Peer Group Xii)
11.4. Concluding Remarks
Section Iv: Company Profiles
12. Company Profiles
12.1. Chapter Overview
12.2. Avania
12.2.1. Company Overview
12.2.2. Service Portfolio
12.2.3. Recent Developments And Future Outlook
12.3. Charles River Laboratories
12.4. Cromsource
12.5. Cssi Lifesciences
12.6. Eurofins Medical Testing
12.7. Iqvia
12.8. Medpace
12.9. Namsa
12.10. Qserve
12.11. Wuxi Apptec
Section V: Market Trends 
13. Mergers And Acquisitions
13.1. Chapter Overview
13.2. Merger And Acquisition Models
13.3. Medical Device Cros: Mergers And Acquisitions
13.3.1. Analysis By Year Of Merger / Acquisition
13.3.2. Analysis By Type Of Agreement
13.3.3. Regional Analysis
13.3.3.1. Analysis By Continent
13.3.3.2. Intercontinental And Intracontinental Deals
13.3.3.3. Analysis By Country
13.3.4. Ownership Change Matrix
13.3.5. Analysis By Type Of Company
13.3.6. Analysis By Key Value Drivers
13.3.6.1. Analysis By Year Of Acquisition And Key Value Drivers
14. Clinical Trial Analysis
14.1. Chapter Overview
14.2. Scope And Methodology
14.3. Clinical Trial Analysis: Medical Devices
14.3.1. Analysis By Trial Registration Year
14.3.2. Analysis Of Number Of Patients Enrolled By Trial Registration Year
14.3.3. Analysis By Trial Phase
14.3.4. Analysis Of Number Of Patients Enrolled By Trial Phase
14.3.5. Analysis By Trial Registration Year And Trial Phase
14.3.6. Analysis By Trial Status
14.3.7. Analysis By Patient Gender
14.3.8. Analysis By Target Indication
14.3.9. Analysis By Study Design
14.3.9.1. Analysis By Type Of Trial Masking
14.3.9.2. Analysis By Type Of Intervention Model
14.3.9.3. Analysis By Trial Purpose
14.3.9.4. Analysis By Design Allocation
14.3.10. Most Active Sponsor / Collaborator: Analysis By Number Of Registered Trials
14.3.10.1. Analysis By Leading Industry Players
14.3.10.2. Analysis By Leading Non-industry Players
14.3.11. Analysis By Geography
14.3.11.1. Analysis Of Clinical Trials By Trial Status And Geography
14.3.11.2. Analysis Of Patients Enrolled By Trial Status And Geography
15. Future Trends And Opportunities
15.1. Chapter Overview
15.2. Anticipated Growth In Number Of Connected Devices
15.3. Adoption Of Data Analytics And Real-time Monitoring Solutions
15.4. Need For Cloud-based Computing And Storage Solutions
15.5. Growing Demand For Real World Evidence To Obtain Regulatory Approval
15.6. Concluding Remarks
Section Vi: Market Forecast And Opportunity Analysis
16. Swot Analysis
16.1. Chapter Overview
16.2. Strengths
16.3. Weaknesses
16.4. Opportunities
16.5. Threats
16.6. Concluding Remarks
17. Global Medical Device Cro Market
17.1. Chapter Overview
17.2. Assumptions And Methodology
17.3. Roots Analysis Perspective On Market Growth
17.4. Global Medical Device Cro Market: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
17.4.1. Scenario Analysis
17.4.1.1. Conservative Scenario
17.4.1.2. Optimistic Scenario
17.5. Key Market Segmentations
18. Medical Device Cro Market, By Class Of Medical Device
18.1. Chapter Overview
18.2. Assumptions And Methodology
18.3. Medical Device Cro Market: Distribution By Class Of Medical Device
18.3.1. Medical Device Cro Market For Class I Medical Devices: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
18.3.2. Medical Device Cro Market For Class Ii Medical Devices: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
18.3.3. Medical Device Cro Market For Class Iii Medical Devices: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
18.4. Market Movement Analysis: Class Of Medical Device
18.5. Penetration-growth (P-g) Matrix: Class Of Medical Device
18.6. Data Triangulation And Validation
19. Medical Device Cro Market, By Type Of Medical Device
19.1. Chapter Overview
19.2. Assumptions And Methodology
19.3. Medical Device Cro Market: Distribution By Type Of Medical Device
19.3.1. Medical Device Cro Market For Medtech Devices: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
19.3.2. Medical Device Cro Market For Diagnostic Devices: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
19.3.3. Medical Device Cro Market For Handheld Diagnostic Devices: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
19.3.4. Medical Device Cro Market For Other Devices: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
19.4. Penetration-growth (P-g) Matrix: Type Of Medical Device
19.5. Data Triangulation And Validation
20. Medical Device Cro Market, By Scale Of Operation
20.1. Chapter Overview
20.2. Assumptions And Methodology
20.3. Medical Device Cro Market: Distribution By Scale Of Operation
20.3.1. Medical Device Cro Market For Preclinical Services: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
20.3.2. Medical Device Cro Market For Clinical Services: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
20.4. Penetration-growth (P-g) Matrix: Scale Of Operation
20.5. Data Triangulation And Validation
21. Medical Device Cro Market, By Type Of Preclinical Service Offered
21.1. Chapter Overview
21.2. Assumptions And Methodology
21.3. Medical Device Cro Market: Distribution By Type Of Preclinical Service Offered
21.3.1. Medical Device Cro Market For Sterility And Microbiology Testing Services: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
21.3.2. Medical Device Cro Market For Biocompatibility Testing Services: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
21.3.3. Medical Device Cro Market For Material Characterization And Analytical Services: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
21.3.4. Medical Device Cro Market For Other Services: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
21.4. Penetration-growth (P-g) Matrix: Type Of Preclinical Service Offered
21.5. Data Triangulation And Validation
22. Medical Device Cro Market, By Type Of Clinical Service Offered
22.1. Chapter Overview
22.2. Assumptions And Methodology
22.3. Medical Device Cro Market: Distribution By Type Of Clinical Service Offered
22.3.1. Medical Device Cro Market For Clinical Trial Management Services: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
22.3.2. Medical Device Cro Market For Data Management Services: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
22.3.3. Medical Device Cro Market For Regulatory Support Services: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
22.3.4. Medical Device Cro Market For Consultancy Services: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
22.3.5. Medical Device Cro Market For Other Services: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
22.4. Penetration-growth (P-g) Matrix: Type Of Clinical Service Offered
22.5. Data Triangulation And Validation
23. Medical Device Cro Market, By Company Size
23.1. Chapter Overview
23.2. Assumptions And Methodology
23.3. Medical Device Cro Market: Distribution By Company Size
23.3.1. Medical Device Cro Market For Small Companies: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
23.3.2. Medical Device Cro Market For Mid-sized Companies: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
23.3.3. Medical Device Cro Market For Large And Very Large Companies: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
23.4. Penetration-growth (P-g) Matrix: Company Size
23.5. Data Triangulation And Validation
24. Medical Device Cro Market, By Type Of Original Equipment Manufacturer
24.1. Chapter Overview
24.2. Assumptions And Methodology
24.3. Medical Device Cro Market: Distribution By Type Of Original Equipment Manufacturer
24.3.1. Medical Device Cro Market For Small And Mid-sized Cros: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
24.3.2. Medical Device Cro Market For Large Cros: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
24.3.3. Medical Device Cro Market For Very Large Cros: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
24.4. Penetration-growth (P-g) Matrix: Type Of Original Equipment Manufacturer
24.5. Data Triangulation And Validation
25. Medical Device Cro Market, By Target Indication
25.1. Chapter Overview
25.2. Assumptions And Methodology
25.3. Medical Device Cro Market: Distribution By Target Indication
25.3.1. Medical Device Cro Market For Cardiovascular Disorders: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
25.3.2. Medical Device Cro Market For Oncological Disorders: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
25.3.3. Medical Device Cro Market For Neurological Disorders: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
25.3.4. Medical Device Cro Market For Orthopedic Disorders: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
25.3.5. Medical Device Cro Market For Respiratory Disorders: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
25.3.6. Medical Device Cro Market For Pain Disorders: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
25.3.7. Medical Device Cro Market For Ophthalmological Disorders: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
25.3.8. Medical Device Cro Market For Psychological Disorders: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
25.3.9. Medical Device Cro Market For Metabolic Disorders: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
25.3.10. Medical Device Cro Market For Other Disorders: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
25.4. Penetration-growth (P-g) Matrix: Target Indication
25.5. Data Triangulation And Validation
26. Medical Device Cro Market, By Geographical Regions
26.1. Chapter Overview
26.2. Assumptions And Methodology
26.3. Medical Device Cro Market: Distribution By Geographical Regions
26.3.1. Medical Device Cro Market In North America: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.1.1. Medical Device Cro Market In The Us: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.1.2. Medical Device Cro Market In Canada: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.2. Medical Device Cro Market In Europe: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.2.1. Medical Device Cro Market In Germany: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.2.2. Medical Device Cro Market In France: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.2.3. Medical Device Cro Market In Italy: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.2.4. Medical Device Cro Market In Spain: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.2.5. Medical Device Cro Market In The Uk: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.2.6. Medical Device Cro Market In Switzerland: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.2.7. Medical Device Cro Market In Poland: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.2.8. Medical Device Cro Market In Belgium: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.2.9. Medical Device Cro Market In Austria: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.2.10. Medical Device Cro Market In The Netherlands: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.2.11. Medical Device Cro Market In Rest Of Europe: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.3. Medical Device Cro Market In Asia-pacific: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.3.1. Medical Device Cro Market In Japan: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.3.2. Medical Device Cro Market In China: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.3.3. Medical Device Cro Market In India: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.3.4. Medical Device Cro Market In South Korea: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.3.5. Medical Device Cro Market In Australia: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.3.6. Medical Device Cro Market In Indonesia: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.3.7. Medical Device Cro Market In Thailand: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.3.8. Medical Device Cro Market In Singapore: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.3.9. Medical Device Cro Market In Rest Of Asia-pacific: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.4. Medical Device Cro Market In Middle East And North Africa: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.4.1. Medical Device Cro Market In Saudi Arabia: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.4.2. Medical Device Cro Market In Egypt: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.4.3. Medical Device Cro Market In Israel: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.4.4. Medical Device Cro Market In Rest Of Middle East And North Africa: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.5. Medical Device Cro Market In Latin America: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.5.1. Medical Device Cro Market In Brazil: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.5.2. Medical Device Cro Market In Mexico: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.5.3. Medical Device Cro Market In Argentina: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.3.5.4. Medical Device Cro Market In Rest Of Latin America: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
26.4. Penetration-growth (P-g) Matrix: Geographical Regions
26.5. Data Triangulation And Validation
27. Medical Device Cro Market, By Leading Players
Section Vii: Case Study
28. Medical Device Developer And Cro Relationships: Key Value Drivers And Performance Indicators
28.1. Chapter Overview
28.2. Overview And Significance Of Key Performance Indicators (Kpis)
28.3. Key Considerations While Selecting Kpis
28.4. Types Of Kpis
28.4.1. Financial Indicators
28.4.1.1. Most Important Kpis
28.4.1.1.1. Financial Stability
28.4.1.1.2. Cost Of Services Offered
28.4.1.1.3. Comparative Analysis Of Financial Indicators
28.4.1.2. Industry Perspective
28.4.1.2.1. Sponsors’ (Big Pharma) Perspective
28.4.1.2.2. Contract Service Providers’ Perspective
28.4.2. Process And Capability Indicators
28.4.2.1. Most Important Kpis
28.4.2.1.1. Proximity To Sponsor
28.4.2.1.2. Capability To Innovate / Mitigate Risk
28.4.2.1.3. Service Portfolio Strength
28.4.2.1.4. Comparative Analysis Of Process And Capability Indicators
28.4.2.2. Industry Perspective
28.4.2.2.1. Sponsors’ (Big Pharma) Perspective
28.4.2.2.2. Contract Service Providers’ Perspective
28.4.3. Market Reputation Indicators
28.4.3.1. Most Important Kpis
28.4.3.1.1. Flexibility / Adaptability
28.4.3.1.2. Time Management
28.4.3.1.3. Quality / Reliability
28.4.3.1.4. Regulatory Compliance / Track Record
28.4.3.1.5. Comparative Analysis Of Market Reputation Indicators
28.4.3.2. Industry Perspective
28.4.3.2.1. Sponsors’ (Big Pharma) Perspective
28.4.3.2.2. Contract Service Providers’ Perspective
28.5. Comparison Of Key Performance Indicators
28.6. Concluding Remarks
29. Total Cost Of Ownership For Medical Devices Cros

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us